Sanofi Pasteur Singapore launches first quadrivalent conjugate meningococcal vaccine

Sanofi Pasteur recently launched Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine), the first and only quadrivalent conjugate vaccine licensed for the prevention of meningococcal disease in Singapore. Menactra® vaccine offers protection against four of the five most common serogroups of the bacterium that cause meningococcal infection, Neisseria meningitidis serogroups [...]